Zevra Therapeutics Inc (ZVRA)

Aug 09, 2025

Zevra ZVRA 2025Q2 Earnings Preview Potential Upside on Data-Driven Regulatory Strategy - AInvest

Aug 09, 2025

Aug 08, 2025

What Makes Zevra Therapeutics (ZVRA) a Good Fit for 'Trend Investing' - Yahoo Finance

Aug 08, 2025

Aug 06, 2025

Zevra Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference | ZVRA Stock News - GuruFocus

Aug 06, 2025

Aug 06, 2025

Zevra Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire

Aug 06, 2025

Aug 06, 2025

Rare Disease Innovator Zevra Therapeutics Sets Key Investor Presentation at Major Growth Conference - Stock Titan

Aug 06, 2025

Aug 05, 2025

Zevra Therapeutics (ZVRA) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Aug 05, 2025

Aug 04, 2025

Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call - GlobeNewswire

Aug 04, 2025

Aug 04, 2025

Zevra Therapeutics to report Q2 2025 results on Aug 12. - AInvest

Aug 04, 2025

Aug 04, 2025

Quant Funds Rotate Into Zevra Therapeutics Inc. StockStock Screener With Smart Filters Highlights Top Picks - metal.it

Aug 04, 2025

Aug 03, 2025

What are the latest earnings results for Zevra Therapeutics Inc.Extraordinary market timing - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Zevra Therapeutics Inc. Stock Analysis and ForecastExponential return rates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Zevra Therapeutics Inc. stock higher in 2025Unlock powerful trading signals and alerts - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is Zevra Therapeutics Inc. company’s growth strategyDiscover top stock picks for aggressive growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Zevra Therapeutics Inc. stockUnlock exclusive stock market forecasts - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Zevra Therapeutics Inc. in the next 12 monthsUnlock hidden market opportunities today - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Zevra Therapeutics Inc. stock in 2025Free Investment Community - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Zevra Therapeutics Inc. as a “Buy”Outstanding capital growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does Zevra Therapeutics Inc. stock perform well during market downturnsFree Market Volatility Navigation Tips - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Zevra Therapeutics Inc. stock overvalued or undervaluedCapitalize on market trends with confidence - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Zevra Therapeutics Inc. a growth stock or a value stockGet daily updates on promising stocks - Jammu Links News

Aug 03, 2025

Aug 02, 2025

How strong is Zevra Therapeutics Inc. company’s balance sheetFree Stock Selection - jammulinksnews.com

Aug 02, 2025

Jul 31, 2025

Does Zevra Therapeutics (ZVRA) Have the Potential to Rally 117.11% as Wall Street Analysts Expect? - sharewise.com

Jul 31, 2025

Jul 31, 2025

Applying Elliott Wave Theory to Zevra Therapeutics Inc.Long Hold Safe Return Strategy Reviewed - metal.it

Jul 31, 2025

Jul 29, 2025

How Zevra Therapeutics Inc. stock performs during market volatilitySecure Capital Picks With Upside Potential Tracked - metal.it

Jul 29, 2025

Jul 29, 2025

Despite currently being unprofitable, Zevra Therapeutics (NASDAQ:ZVRA) has delivered a 102% return to shareholders over 3 years - simplywall.st

Jul 29, 2025

Jul 28, 2025

What institutional investors are buying Zevra Therapeutics Inc. stockMarket Forecast Alerts For Smart Trading - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Zevra Therapeutics' Strategic Expansion into the European Market with Arimoclomol for NPC: A Deep Dive into Regulatory, Commercial, and Market Access Potential - AInvest

Jul 28, 2025

Jul 28, 2025

Zevra Therapeutics Submits Marketing Authorization Application t - GuruFocus

Jul 28, 2025

Jul 28, 2025

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C | ZVRA Stock News - GuruFocus

Jul 28, 2025

Jul 28, 2025

ZVRA: Zevra Therapeutics Seeks EMA Approval for NPC Drug Arimoclomol - GuruFocus

Jul 28, 2025

Jul 28, 2025

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C - GlobeNewswire

Jul 28, 2025

Jul 28, 2025

Zevra's Breakthrough NPC Treatment Heads to EMA Review: 270+ Patient Data Shows Promise - Stock Titan

Jul 28, 2025

Jul 27, 2025

Intrinsic Value of Zevra Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree High-Accuracy Stock Picks - metal.it

Jul 27, 2025

Jul 27, 2025

Published on: 2025-07-28 03:53:57 - Jammu Links News

Jul 27, 2025

Jul 26, 2025

Is Zevra Therapeutics Inc. stock overhyped or has real potentialMarket Timing Advice - metal.it

Jul 26, 2025

Jul 26, 2025

What makes Zevra Therapeutics Inc. stock price move sharplyFree Deep Market Trend Analysis - metal.it

Jul 26, 2025

Jul 25, 2025

What drives Zevra Therapeutics Inc. stock priceSky-high profits - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about Zevra Therapeutics Inc. stockSuperior stock growth - PrintWeekIndia

Jul 25, 2025

Jul 23, 2025

Is Zevra Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - Jammu Links News

Jul 23, 2025